[go: up one dir, main page]

AU2001253479A1 - Targeted therapeutic agent release devices and methods of making and using the same - Google Patents

Targeted therapeutic agent release devices and methods of making and using the same

Info

Publication number
AU2001253479A1
AU2001253479A1 AU2001253479A AU5347901A AU2001253479A1 AU 2001253479 A1 AU2001253479 A1 AU 2001253479A1 AU 2001253479 A AU2001253479 A AU 2001253479A AU 5347901 A AU5347901 A AU 5347901A AU 2001253479 A1 AU2001253479 A1 AU 2001253479A1
Authority
AU
Australia
Prior art keywords
making
methods
same
therapeutic agent
release devices
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001253479A
Inventor
Daniel Hullihen
Michael R. Violante
Frank Wang
Richard J. Whitbourne
Xianping Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Angiotech Biocoatings Corp
Original Assignee
STS Biopolymers Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by STS Biopolymers Inc filed Critical STS Biopolymers Inc
Publication of AU2001253479A1 publication Critical patent/AU2001253479A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606—Coatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
AU2001253479A 2000-04-13 2001-04-12 Targeted therapeutic agent release devices and methods of making and using the same Abandoned AU2001253479A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19678100P 2000-04-13 2000-04-13
US60196781 2000-04-13
PCT/US2001/012159 WO2001078626A1 (en) 2000-04-13 2001-04-12 Targeted therapeutic agent release devices and methods of making and using the same

Publications (1)

Publication Number Publication Date
AU2001253479A1 true AU2001253479A1 (en) 2001-10-30

Family

ID=22726783

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001253479A Abandoned AU2001253479A1 (en) 2000-04-13 2001-04-12 Targeted therapeutic agent release devices and methods of making and using the same

Country Status (3)

Country Link
US (1) US8101200B2 (en)
AU (1) AU2001253479A1 (en)
WO (1) WO2001078626A1 (en)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2179646T3 (en) * 1998-04-27 2003-01-16 Surmodics Inc COATING THAT RELEASES A BIOACTIVE AGENT.
US7771468B2 (en) * 2001-03-16 2010-08-10 Angiotech Biocoatings Corp. Medicated stent having multi-layer polymer coating
DE60328486D1 (en) * 2002-05-24 2009-09-03 Angiotech Int Ag COMPOSITIONS AND METHODS FOR COATING MEDICAL IMPLANTS
US8313760B2 (en) * 2002-05-24 2012-11-20 Angiotech International Ag Compositions and methods for coating medical implants
US7097850B2 (en) * 2002-06-18 2006-08-29 Surmodics, Inc. Bioactive agent release coating and controlled humidity method
US20030232087A1 (en) * 2002-06-18 2003-12-18 Lawin Laurie R. Bioactive agent release coating with aromatic poly(meth)acrylates
AU2003258230A1 (en) * 2002-08-13 2004-02-25 Medtronic, Inc Medical device exhibiting improved adhesion between polymeric coating and substrate
CA2494187A1 (en) * 2002-08-13 2004-02-19 Medtronic, Inc. Active agent delivery system including a polyurethane, medical device, and method
DE60331552D1 (en) * 2002-08-13 2010-04-15 Medtronic Inc PHARMACEUTICALS COMPOSITIONS USING POLY (ETHYLENE-CO (METH) ACRYLATE, MEDICAL DEVICE AND METHOD
US20040086569A1 (en) * 2002-08-13 2004-05-06 Medtronic, Inc. Active agent delivery systems, medical devices, and methods
EP1539265B1 (en) * 2002-08-13 2007-09-26 Medtronic, Inc. Active agent delivery system including a hydrophobic cellulose derivate
AU2003265446A1 (en) * 2002-08-13 2004-02-25 Medtronic, Inc. Active agent delivery system including a hydrophilic polymer, medical device, and method
AU2003277023B2 (en) * 2002-09-26 2009-02-26 Endovascular Devices, Inc. Apparatus and method for delivery of mitomycin through an eluting biocompatible implantable medical device
US20040260272A1 (en) * 2002-10-22 2004-12-23 Friedman Craig D. Method and system for intravesicular delivery of therapeutic agents
US8246974B2 (en) * 2003-05-02 2012-08-21 Surmodics, Inc. Medical devices and methods for producing the same
EP1633320A2 (en) * 2003-05-02 2006-03-15 SurModics, Inc. Implantable controlled release bioactive agent delivery device
AU2004241111B2 (en) 2003-05-15 2010-05-27 Dsm Ip Assets B.V Manufacture and use of implantable reticulated elastomeric matrices
WO2005018697A2 (en) * 2003-08-13 2005-03-03 Medtronic, Inc. Active agent delivery systems, including a single layer of a miscible polymer blend, medical devices, and methods
WO2005018702A2 (en) * 2003-08-13 2005-03-03 Medtronic, Inc. Active agent delivery systems including a miscible polymer blend, medical devices, and methods
US7763077B2 (en) 2003-12-24 2010-07-27 Biomerix Corporation Repair of spinal annular defects and annulo-nucleoplasty regeneration
DE602005015564D1 (en) * 2004-04-06 2009-09-03 Surmodics Inc COATING COMPOSITIONS FOR BIOACTIVE AGENTS
US20060083772A1 (en) * 2004-04-06 2006-04-20 Dewitt David M Coating compositions for bioactive agents
US20070190108A1 (en) * 2004-05-17 2007-08-16 Arindam Datta High performance reticulated elastomeric matrix preparation, properties, reinforcement, and use in surgical devices, tissue augmentation and/or tissue repair
CA2586927A1 (en) * 2004-11-09 2006-05-18 Angiotech Biocoatings Corp. Antimicrobial needle coating for extended infusion
US20060116714A1 (en) * 2004-11-26 2006-06-01 Ivan Sepetka Coupling and release devices and methods for their assembly and use
JP5178506B2 (en) * 2005-03-14 2013-04-10 バイオベンション ホールディングス リミテッド Methods related to drug delivery compositions
US9884142B2 (en) * 2006-06-13 2018-02-06 Alchimedics Drug eluting stent with a biodegradable release layer attached with an electro-grafted primer coating
US11039942B2 (en) 2006-06-13 2021-06-22 Sino Medical Sciences Technology Inc. Drug eluting stent and method of use of the same for enabling restoration of functional endothelial cell layers
US8685421B2 (en) * 2006-07-07 2014-04-01 Surmodics, Inc. Beaded wound spacer device
WO2008074027A1 (en) * 2006-12-13 2008-06-19 Biomerix Corporation Aneurysm occlusion devices
JP2010512947A (en) 2006-12-20 2010-04-30 ボストン サイエンティフィック リミテッド Stent with coating for delivering therapeutic agent
EP2144640B1 (en) * 2007-04-17 2012-03-28 Medtronic, Inc. Reduction of infection associated with medical device
DE102007039871A1 (en) * 2007-08-21 2009-02-26 Friedrich-Baur-Gmbh Soft tissue implant with antibacterial effect
US9265633B2 (en) 2009-05-20 2016-02-23 480 Biomedical, Inc. Drug-eluting medical implants
DK2338535T3 (en) * 2009-12-18 2012-09-24 Dentsply Ih Ab Medical device for short-term use with fast-releasing antibacterial agent
JP5869672B2 (en) * 2011-08-02 2016-02-24 スリーエム イノベイティブ プロパティズ カンパニー Graphic goods
US9308773B2 (en) 2011-08-02 2016-04-12 3M Innovative Properties Company Graphic article
US9827401B2 (en) 2012-06-01 2017-11-28 Surmodics, Inc. Apparatus and methods for coating medical devices
EP2855030B1 (en) 2012-06-01 2019-08-21 SurModics, Inc. Apparatus and method for coating balloon catheters
CA2888241C (en) 2012-10-16 2020-12-29 Surmodics, Inc. Wound packing device and methods
US11090468B2 (en) 2012-10-25 2021-08-17 Surmodics, Inc. Apparatus and methods for coating medical devices
CN104174074B (en) * 2013-11-27 2016-05-18 浙江归创医疗器械有限公司 A kind of medication coat composition that is applicable to be coated in implantation or interventional medical device surface
CN103736154B (en) * 2013-12-26 2015-06-17 先健科技(深圳)有限公司 Medicinal coating balloon catheter
US10201457B2 (en) 2014-08-01 2019-02-12 Surmodics, Inc. Wound packing device with nanotextured surface
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
CA2965509C (en) 2014-10-24 2023-03-14 Avectas Limited Delivery across cell plasma membranes
US20160346219A1 (en) 2015-06-01 2016-12-01 Autotelic Llc Phospholipid-coated therapeutic agent nanoparticles and related methods
GB201512030D0 (en) 2015-07-09 2015-08-19 Jmedtech Pte Ltd Composition
CA3009715A1 (en) 2015-12-30 2017-07-06 Avectas Limited Vector-free delivery of gene editing proteins and compositions to cells and tissues
AU2017295710B2 (en) 2016-07-14 2021-11-11 Hollister Incorporated Hygienic medical devices having hydrophilic coating and methods of forming the same
US11628466B2 (en) 2018-11-29 2023-04-18 Surmodics, Inc. Apparatus and methods for coating medical devices
US11819590B2 (en) 2019-05-13 2023-11-21 Surmodics, Inc. Apparatus and methods for coating medical devices
EP3993715B1 (en) * 2019-07-04 2024-04-17 F. Hoffmann-La Roche AG Implantation needle for inserting a subcutaneously insertable element into a body tissue
US12496612B2 (en) 2021-01-08 2025-12-16 Surmodics, Inc. Coating application system and methods for coating rotatable medical devices

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4531933A (en) * 1982-12-07 1985-07-30 C. R. Bard, Inc. Helical ureteral stent
US4723957A (en) 1986-02-07 1988-02-09 Alza Corp. System for delivering drug with enhanced bioacceptability
US5059211A (en) * 1987-06-25 1991-10-22 Duke University Absorbable vascular stent
US5001009A (en) 1987-09-02 1991-03-19 Sterilization Technical Services, Inc. Lubricious hydrophilic composite coated on substrates
US5069899A (en) * 1989-11-02 1991-12-03 Sterilization Technical Services, Inc. Anti-thrombogenic, anti-microbial compositions containing heparin
US5525348A (en) * 1989-11-02 1996-06-11 Sts Biopolymers, Inc. Coating compositions comprising pharmaceutical agents
GB8926639D0 (en) * 1989-11-24 1990-01-17 Agricultural & Food Res Delayed release formulations
IL98087A (en) 1990-05-04 1996-11-14 Perio Prod Ltd Colonic drug delivery system
US5811447A (en) * 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6515009B1 (en) * 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
GB9314960D0 (en) 1992-07-23 1993-09-01 Zeneca Ltd Chemical compounds
US6306421B1 (en) * 1992-09-25 2001-10-23 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6491938B2 (en) * 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5523092A (en) * 1993-04-14 1996-06-04 Emory University Device for local drug delivery and methods for using the same
US5886026A (en) * 1993-07-19 1999-03-23 Angiotech Pharmaceuticals Inc. Anti-angiogenic compositions and methods of use
ATE314845T1 (en) * 1993-07-29 2006-02-15 Us Health USE OF PACLITAXEL AND ITS DERIVATIVES FOR THE PRODUCTION OF A MEDICATION FOR THE TREATMENT OF RESTENOSES
US5589120A (en) * 1994-08-22 1996-12-31 Becton Dickinson And Company Process of making a shaped tip on a catheter
US5891108A (en) * 1994-09-12 1999-04-06 Cordis Corporation Drug delivery stent
US5707385A (en) * 1994-11-16 1998-01-13 Advanced Cardiovascular Systems, Inc. Drug loaded elastic membrane and method for delivery
PT800578E (en) 1994-12-28 2003-09-30 Univ Kentucky SEQUENCES OF THE 3H1 ANTI-IDIOTIPIC RECOMBINANT MONOCLONAL ANTIBODY ASSOCIATED WITH HUMAN CARCIOEMBRIANARY ANTIGEN
US5609629A (en) * 1995-06-07 1997-03-11 Med Institute, Inc. Coated implantable medical device
US5779673A (en) 1995-06-26 1998-07-14 Focal, Inc. Devices and methods for application of intraluminal photopolymerized gels
US5773019A (en) * 1995-09-27 1998-06-30 The University Of Kentucky Research Foundation Implantable controlled release device to deliver drugs directly to an internal portion of the body
US6231888B1 (en) * 1996-01-18 2001-05-15 Perio Products Ltd. Local delivery of non steroidal anti inflammatory drugs (NSAIDS) to the colon as a treatment for colonic polyps
CN1304058C (en) 1996-03-12 2007-03-14 Pg－Txl有限公司 Water Soluble Paclitaxel Products
US6783543B2 (en) * 2000-06-05 2004-08-31 Scimed Life Systems, Inc. Intravascular stent with increasing coating retaining capacity
US7070590B1 (en) * 1996-07-02 2006-07-04 Massachusetts Institute Of Technology Microchip drug delivery devices
US5797898A (en) * 1996-07-02 1998-08-25 Massachusetts Institute Of Technology Microchip drug delivery devices
US5800412A (en) 1996-10-10 1998-09-01 Sts Biopolymers, Inc. Hydrophilic coatings with hydrating agents
ATE279213T1 (en) 1996-11-06 2004-10-15 Sts Biopolymers Inc COATING WITH GAS-CONTAINING CAVITIES TO AMPLIFY ULTRASONIC ECHOS
ZA9710342B (en) 1996-11-25 1998-06-10 Alza Corp Directional drug delivery stent and method of use.
US6515016B2 (en) * 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
IT1289815B1 (en) 1996-12-30 1998-10-16 Sorin Biomedica Cardio Spa ANGIOPLASTIC STENT AND RELATED PRODUCTION PROCESS
US5997517A (en) * 1997-01-27 1999-12-07 Sts Biopolymers, Inc. Bonding layers for medical device surface coatings
US5843172A (en) * 1997-04-15 1998-12-01 Advanced Cardiovascular Systems, Inc. Porous medicated stent
US6273913B1 (en) 1997-04-18 2001-08-14 Cordis Corporation Modified stent useful for delivery of drugs along stent strut
US5840329A (en) 1997-05-15 1998-11-24 Bioadvances Llc Pulsatile drug delivery system
US6110483A (en) * 1997-06-23 2000-08-29 Sts Biopolymers, Inc. Adherent, flexible hydrogel and medicated coatings
US5994309A (en) 1997-07-25 1999-11-30 Angstrom Pharmaceuticals, Inc. Anti-invasive and anti-angiogenic compositions and methods
US5972027A (en) * 1997-09-30 1999-10-26 Scimed Life Systems, Inc Porous stent drug delivery system
US6273908B1 (en) * 1997-10-24 2001-08-14 Robert Ndondo-Lay Stents
US7208010B2 (en) * 2000-10-16 2007-04-24 Conor Medsystems, Inc. Expandable medical device for delivery of beneficial agent
US6241762B1 (en) * 1998-03-30 2001-06-05 Conor Medsystems, Inc. Expandable medical device with ductile hinges
US5980550A (en) * 1998-06-18 1999-11-09 Target Therapeutics, Inc. Water-soluble coating for bioactive vasoocclusive devices
US20010032011A1 (en) * 1999-07-20 2001-10-18 Stanford Ulf Harry Expandable stent with array of relief cuts
US20050283228A1 (en) * 1998-07-29 2005-12-22 Stanford Ulf H Expandable stent with relief holes capable of carrying medicines and other materials
US6335029B1 (en) * 1998-08-28 2002-01-01 Scimed Life Systems, Inc. Polymeric coatings for controlled delivery of active agents
US6293967B1 (en) * 1998-10-29 2001-09-25 Conor Medsystems, Inc. Expandable medical device with ductile hinges
CA2392006C (en) * 1999-11-17 2011-03-15 Microchips, Inc. Microfabricated devices for the delivery of molecules into a carrier fluid
EP1132058A1 (en) 2000-03-06 2001-09-12 Advanced Laser Applications Holding S.A. Intravascular prothesis
US6395326B1 (en) * 2000-05-31 2002-05-28 Advanced Cardiovascular Systems, Inc. Apparatus and method for depositing a coating onto a surface of a prosthesis
US6254632B1 (en) * 2000-09-28 2001-07-03 Advanced Cardiovascular Systems, Inc. Implantable medical device having protruding surface structures for drug delivery and cover attachment
US6663662B2 (en) * 2000-12-28 2003-12-16 Advanced Cardiovascular Systems, Inc. Diffusion barrier layer for implantable devices
ES2266148T5 (en) * 2001-07-20 2012-11-06 Sorin Biomedica Cardio S.R.L. Stent
WO2005049105A2 (en) * 2003-11-10 2005-06-02 Angiotech International Ag Medical implants and anti-scarring agents

Also Published As

Publication number Publication date
WO2001078626A1 (en) 2001-10-25
US20020018795A1 (en) 2002-02-14
US8101200B2 (en) 2012-01-24

Similar Documents

Publication Publication Date Title
AU2001253479A1 (en) Targeted therapeutic agent release devices and methods of making and using the same
AU2001285020A1 (en) P97-active agent conjugates and their methods of use
AU2002211389A1 (en) Microfluidic devices and methods of use
GB0415630D0 (en) Sustained release ophthalmological device and method of making and using the same
AU6118001A (en) Combination therapeutic compositions and methods of use
AU2002320058A1 (en) Magnetic-nanoparticle conjugates and methods of use
AU2001280455A1 (en) Therapeutic device and system
AU2002327358A1 (en) Methods and devices for delivery of therapeutic capable agents with variable release profile
AU2002211276A1 (en) Selective coating of medical devices
AU2002356530A1 (en) Medical devices comprising nanomaterials and therapeutic methods utilizing the same
AU2001253411A1 (en) Medical dressing assembly and associated method of using the same
AU2002227184A1 (en) Methods for development and use of diagnostic and therapeutic agents
AU2001233296A1 (en) Establishing and maintaining therapeutic hypothermia
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2002314466A1 (en) Withasol and methods of use
AU2001289308A1 (en) Targeted agents useful for diagnostic and therapeutic applications
AU715620C (en) Therapeutic methods and uses
AU4848200A (en) Intravascular device and methods of manufacture and use
AU2002252976A1 (en) Hydrazones and their therapeutic use
AU2002213346A1 (en) Osteopontin-coated surfaces and methods of use
AU2002359618A1 (en) Medicinal compositions and therapeutic methods
AU2002221273A1 (en) Delayed and sustained release formulations and method of use thereof
AU2002363800A1 (en) Therapeutic agent composition and method of use
AU2001261496A1 (en) Luxo-sigma54 interactions and methods of use
AU2001249692A1 (en) Phospholipid scramblases and methods of use thereof